Compare AstraZeneca plc (AZN) vs Eni SpA (E) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Eni SpA — how do they compare? AstraZeneca plc trades at $166.64 (market cap $253.13B), while Eni SpA trades at $49.51 (market cap $71.95B). The key difference: AstraZeneca plc is far larger — about 3.5× Eni SpA's market cap, and Eni SpA pays the higher dividend (4.93%). Which is the better fit depends on your goals.
| AZN | E | |
|---|---|---|
Market Cap | $253.13B | $71.95B |
Sector | Health | Energy |
52-Week High | $209.48 | $57.61 |
52-Week Low | $137.44 | $32.93 |
Enterprise Value | $279.37B | $90.86B |
Dividend Yield | 1.92% | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eni (E) trades at $49.44, up 3.6% with a bullish technical signal supported by moving averages. The stock shows attractive valuation with P/E of 21.81 and P/S of 0.8, though revenue has declined from $132.5B in 2022 to $82.15B in 2025. Recent strategic moves include lithium investments in Chile, fusion energy partnerships, and global gas portfolio expansion. The company maintains positive cash flow with $238M net cash flow in 2025 and pays a $0.63 dividend.
Eni presents a mixed outlook with strong diversification efforts offset by declining revenue trends. The stock offers value characteristics with below-market valuations and dividend income, but faces headwinds from volatile energy markets and execution risks in new ventures. Analyst consensus leans cautious with 62% hold ratings, suggesting patience may be warranted despite current bullish technical momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →
